Reversing Alzheimer’s - The Bredesen Protocol. Test P-tau proteins for early signs of damage.

Dale Bredesen, MD and several his colleagues around the country have been reversing dementia for over ten years. Case studies of 100 of their patients were published in the journal of Alzheimer’s and Parkinsonism in 2018. Their proof of concept study was published in the Journal of Alzheimer’s in 2022, with a follow up in 2023. A customized approach based on these proven principles, for anyone concerned about dementia, is available now.

P-tau 217: A blood test just shown in research published in JAMA in January 2024 to be as accurate as much more invasive cerebral spinal fluid testing. The average age of the 786 participants was 66 years old, but the study suggests that it should be valid for predicting risk in people much younger than this.

This show aired on KDAR 98.3 FM, Friday, April 5, 2024.